Biosimilars

The US FDA Approves High Concentration of Boehringer Ingelheim's Cyltezo (Biosimilar, Humira)

The US FDA Approves High Concentration of Boehringer Ingelheim's Cyltezo (Biosimilar, Humira)

Shots: Boehringer Ingelheim has received the US FDA’s approval for the high-...

Biogen Receives EMA’s CHMP Positive Opinion for Tofidence (Biosimilar, Roactemra)

Biogen Receives EMA’s CHMP Positive Opinion for Tofidence (Biosimilar, Roactemra)

Shots:  The EMA’s CHMP has issued a positive opinion recommending appro...

Samsung Bioepis Receives EC’s Marketing Authorization for Pyzchiva (Biosimilar, Stelara) to treat Autoimmune disorders

Samsung Bioepis Receives EC’s Marketing Authorization for Pyzchiva (Biosimilar, Stelara) to treat Autoimmune disorders

Shots:  The EC has granted marketing authorization for Pyzchiva (Biosimilar,&...

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Shots: The US FDA has approved Selarsdi (ustekinumab-aekn) injection (SC) for adul...

Fresenius Kabi Launches Tyenne (Biosimilar, Actemra; IV) to Treat Chronic Autoimmune diseases

Fresenius Kabi Launches Tyenne (Biosimilar, Actemra; IV) to Treat Chronic Autoimmune diseases

Shots:    The company has launched Tyenne (biosimilar, Actemra) in...

Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

Shots: Henlius and Organon revealed results from the

Image